Kendric Cromer
12-year-old who became the first to start new sickle cell treatment discharged from hospital
After 44 days, Kendric Cromer, the world’s first sickle cell patient to start commercially licensed gene therapy, was finally discharged from the hospital last Wednesday. One study estimates that approximately 100,000 people in the United States suffer from sickle cell disease, with Black people making up a large percentage of those affected. The 12-year-old Washington…
